Rapamycin ameliorates doxorubicin-induced cardiomyopathy through suppression of RIPK1-independent necroptosis

Back

ESC Professional Premium Access

Rapamycin ameliorates doxorubicin-induced cardiomyopathy through suppression of RIPK1-independent necroptosis

Session: Molecular cardio-oncology

Topic: Drugs, Drug Targets

Speaker: Doctor M. Shimizu (Sapporo, JP)

Event: ESC Congress 2023

Congress Presentation

About the speaker

Doctor Masaki Shimizu

Sapporo Medical University, Sapporo (Japan)

0 follower

5 more presentations in this session

Heart failure stimulates colorectal tumour growth through gut microbial alterations of specific populations

Speaker: Ms S. De Wit (Groningen, NL)

Cardiometabolic rewiring in the context of doxorubicin-induced cardiotoxicity: fuel preference changes from fatty acids to glucose oxidation

Speaker: Doctor G. Guerra (Turin, IT)

CaMKIIdelta-mediated SR Ca leak contributes to long-term Doxorubicin-induced cardiotoxicity

Speaker: Miss A. Feder (DE)

The clinically active PARP inhibitor olaparib ameliorates doxorubicin-induced cardiotoxicity in both in vitro and in vivo model

Speaker: Ms D. Chen (Newcastle, AU)

Glycogen Synthase Kinase 3 beta confers refractoriness to the microRNA-210-elicited exacerbation of hypoxia-reoxygenation stress-induced apoptotic cell death

Speaker: Doctor G. Marwarha (Trondheim, NO)

Access

Abstract

Slides

Access the full session

Molecular cardio-oncology

Speakers: Doctor M. Shimizu, Ms S. De Wit, Doctor G. Guerra, Miss A. Feder, Ms D. Chen...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

Rapamycin ameliorates doxorubicin-induced cardiomyopathy through suppression of RIPK1-independent necroptosis

About the speaker

Doctor Masaki Shimizu

5 more presentations in this session

Heart failure stimulates colorectal tumour growth through gut microbial alterations of specific populations

Cardiometabolic rewiring in the context of doxorubicin-induced cardiotoxicity: fuel preference changes from fatty acids to glucose oxidation

CaMKIIdelta-mediated SR Ca leak contributes to long-term Doxorubicin-induced cardiotoxicity

The clinically active PARP inhibitor olaparib ameliorates doxorubicin-induced cardiotoxicity in both in vitro and in vivo model

Glycogen Synthase Kinase 3 beta confers refractoriness to the microRNA-210-elicited exacerbation of hypoxia-reoxygenation stress-induced apoptotic cell death

Access the full session

Molecular cardio-oncology

About the event

ESC Congress 2023

ESC 365 is supported by